{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T11:56:05Z","timestamp":1769946965324,"version":"3.49.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"48","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.vaccine.2022.10.017","type":"journal-article","created":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T19:30:46Z","timestamp":1666467046000},"page":"6963-6970","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Phenotypic and functional changes of T cell subsets after CoronaVac vaccination"],"prefix":"10.1016","volume":"40","author":[{"given":"Wisitsak","family":"Phoksawat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnone","family":"Nithichanon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hatairat","family":"Lerdsamran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surasakdi","family":"Wongratanacheewin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atibordee","family":"Meesing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chonlatip","family":"Pipattanaboon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakawrat","family":"Kanthawong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sirinart","family":"Aromseree","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umaporn","family":"Yordpratum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marut","family":"Laohaviroj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viraphong","family":"Lulitanond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sorujsiri","family":"Chareonsudjai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilaipan","family":"Puthavathana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludthawun","family":"Kamuthachad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chatcharin","family":"Kamsom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chakrit","family":"Thapphan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanin","family":"Salao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arunya","family":"Chonlapan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Punnapat","family":"Nawawishkarun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jarunee","family":"Prasertsopon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans J.","family":"Overgaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven W.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Supranee","family":"Phanthanawiboon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.vaccine.2022.10.017_b0005","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/s41576-021-00408-x","article-title":"The biological and clinical significance of emerging SARS-CoV-2 variants","volume":"22","author":"Tao","year":"2021","journal-title":"Nat Rev Genet"},{"issue":"10","key":"10.1016\/j.vaccine.2022.10.017_b0010","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1038\/s41562-021-01212-7","article-title":"Why lockdown and distance learning during the COVID-19 pandemic are likely to increase the social class achievement gap","volume":"5","author":"Goudeau","year":"2021","journal-title":"Nat Hum Behav"},{"issue":"2","key":"10.1016\/j.vaccine.2022.10.017_b0015","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1473-3099(20)30843-4","article-title":"Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18\u201359 years: a randomised, double-blind, placebo-controlled, phase 1\/2 clinical trial","volume":"21","author":"Zhang","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2022.10.017_b0020","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-020-04775-4","volume":"21","author":"Palacios","year":"2020","journal-title":"Trials"},{"issue":"10","key":"10.1016\/j.vaccine.2022.10.017_b0025","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/S1473-3099(21)00568-5","article-title":"CoronaVac induces lower neutralising activity against variants of concern than natural infection","volume":"21","author":"Vacharathit","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2022.10.017_b0030","doi-asserted-by":"crossref","unstructured":"Bueno SM, Abarca K, Gonz\u00e1lez PA, G\u00e1lvez NM, Soto JA, Duarte LF, et al. Interim report: Safety and immunogenicity of an inactivated vaccine against SARS-CoV-2 in healthy chilean adults in a phase 3 clinical trial. medRxiv 2021; published online April 1. http:\/\/doi.org\/10.1101\/2021.03.31.21254494.","DOI":"10.1101\/2021.03.31.21254494"},{"key":"10.1016\/j.vaccine.2022.10.017_b0035","doi-asserted-by":"crossref","unstructured":"Suphanchaimat R, Teekasap P, Nottayasoot N, Phaiarom M, Cetthakrikul N. Forecasted trends of the new COVID-19 epiemic due to the omicron variant in Thailand, 2022. Vaccines 2022;10:1024. doi.org\/10.3390\/vaccines10071024.","DOI":"10.3390\/vaccines10071024"},{"issue":"11","key":"10.1016\/j.vaccine.2022.10.017_b0040","doi-asserted-by":"crossref","first-page":"e0241164","DOI":"10.1371\/journal.pone.0241164","article-title":"Testing IgG antibodies against the RBD of SARS-CoV-2 is sufficient and necessary for COVID-19 diagnosis","volume":"15","author":"Indenbaum","year":"2020","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.vaccine.2022.10.017_b0045","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1038\/s41596-021-00536-y","article-title":"Quantification of SARS-CoV-2 neutralizing antibody by wild-type plaque reduction neutralization, microneutralization and pseudotyped virus neutralization assays","volume":"16","author":"Bewley","year":"2021","journal-title":"Nat Protoc"},{"key":"10.1016\/j.vaccine.2022.10.017_b0050","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/978-1-4939-7346-0_9","article-title":"Multiparameter Intracellular Cytokine Staining","volume":"1678","author":"Lovelace","year":"2018","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.vaccine.2022.10.017_b0055","doi-asserted-by":"crossref","DOI":"10.3791\/54582","article-title":"The Isolation, Differentiation, and Quantification of Human Antibody-secreting B Cells from Blood: ELISpot as a Functional Readout of Humoral Immunity","author":"Tzeng","year":"2016","journal-title":"J Vis Exp"},{"key":"10.1016\/j.vaccine.2022.10.017_b0060","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.2147\/JAA.S333098","article-title":"CoronaVac COVID-19 Vaccine-Induced Anaphylaxis: Clinical Characteristics and Revaccination Outcomes","volume":"Volume 14","author":"Laisuan","year":"2021","journal-title":"J Asthma Allergy"},{"issue":"6","key":"10.1016\/j.vaccine.2022.10.017_b0065","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1161\/CIRCULATIONAHA.121.056135","article-title":"Myocarditis With COVID-19 mRNA Vaccines","volume":"144","author":"Bozkurt","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.vaccine.2022.10.017_b0070","doi-asserted-by":"crossref","unstructured":"Zee JST, Lai KTW, Ho MKS, Leung ACP, Fung LH, Luk WP, et al. Serological response to mRNA and inactivated COVID-19 vaccine in healthcare workers in Hong Kong: decline in antibodies 12 weeks after two doses. Hong Kong Med J 2021;27:380\u201383.","DOI":"10.12809\/hkmj219744"},{"issue":"10","key":"10.1016\/j.vaccine.2022.10.017_b0075","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1038\/s41591-021-01469-5","article-title":"Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial","volume":"27","author":"Medeiros-Ribeiro","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2022.10.017_b0080","article-title":"Dynamic SARS-CoV-2 specific B cell and T cell responses following immunization of an inactivated COVID-19 vaccine","author":"Chen","year":"2021","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.vaccine.2022.10.017_b0085","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/jmv.27350","article-title":"SARS-CoV-2 specific antibody responses after third CoronaVac or BNT162b2 vaccine following two-dose CoronaVac vaccine regimen","volume":"94","author":"Keskin","year":"2022","journal-title":"J Med Virol"},{"issue":"11","key":"10.1016\/j.vaccine.2022.10.017_b0090","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1038\/s41423-021-00776-8","article-title":"Significantly reduced abilities to cross-neutralize SARS-CoV-2 variants by sera from convalescent COVID-19 patients infected by Delta or early strains","volume":"18","author":"Pan","year":"2021","journal-title":"Cell Mol Immunol"},{"issue":"7830","key":"10.1016\/j.vaccine.2022.10.017_b0095","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41586-020-2814-7","article-title":"COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses","volume":"586","author":"Sahin","year":"2020","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.vaccine.2022.10.017_b0100","doi-asserted-by":"crossref","first-page":"957","DOI":"10.4161\/hv.23774","article-title":"High proportions of regulatory B and T cells are associated with decreased cellular responses to pH1N1 influenza vaccine in HIV-infected children and youth (IMPAACT P1088)","volume":"9","author":"Weinberg","year":"2013","journal-title":"Hum Vaccin Immunother"},{"issue":"9","key":"10.1016\/j.vaccine.2022.10.017_b0105","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.3390\/vaccines9091028","article-title":"Immunological Analysis of People in Northeast China after SARS-CoV-2 Inactivated Vaccine Injection","volume":"9","author":"Fu","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2022.10.017_b0110","doi-asserted-by":"crossref","unstructured":"Ranzani OT, Hitchings MDT, Dorion M, D'Agostini TL, de Paula RC, de Paula OFP, et al. Effectiveness of the CoronaVac vaccine in older adults during a gamma variant associated epidemic of covid-19 in Brazil: test negative case-control study. BMJ 2021; published online August 20. http:\/\/doi.org\/10.1136\/bmj.n2015.","DOI":"10.1136\/bmj.n2015"},{"issue":"1","key":"10.1016\/j.vaccine.2022.10.017_b0115","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/jmv.27318","article-title":"Should a third booster dose be scheduled after two doses of CoronaVac? A single-center experience","volume":"94","author":"Yigit","year":"2022","journal-title":"J Med Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22012658?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22012658?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:18:14Z","timestamp":1759403894000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22012658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":23,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0264410X22012658"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.10.017","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenotypic and functional changes of T cell subsets after CoronaVac vaccination","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}